Bacillus subtilis strain with probiotic activity

US11173184B2 · kind B2 · utility

Assignee

• Evonik Operations GmbH · DE

Inventors

• Daniel Petri · Wien, AT
• Stefan Pelzer · Gütersloh, DE
• Jessica KLEINBÖLTING · Bielefeld, DE
• Stella Molck · Bielefeld, DE
• Maike Kipker · Essen, DE
• Claudia Borgmeier · Bensheim, DE
• Sandra Herbold · Mannheim, DE
• Guido Meurer · Seeheim-Jugenheim, DE
• Rose WHELAN · Offenbach, DE
• Kiran Doranalli · Frankfurt, DE

Key dates

• Filing date: May 29, 2017
• Grant date: Nov 16, 2021
• Expiry date: May 29, 2037

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C12R2001/125
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The current invention concerns a new B. subtilis strain with strong inhibition of C. perfringens and its use as a probiotic.